Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.
Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).
Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.
COPD exacerbations apart from making you feel terrible for a few days, there is a risk that it could end up leading to a hospitalization. Which is obviously a concerning outcome where you may need ...
If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...
The problem with COPD is you have obstruction ... is to keep them from having exacerbations of their disease. What I usually tell patients to look for in a flare-up is: Is their mucus getting ...
The trick is finding the right treatment plan for you ... you’re having what’s called a COPD flare-up or exacerbation. “You go from feeling crappy to feeling really crappy,” Dr ...
The following is a summary of “Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a ...
Among patients with COPD who experienced an exacerbation, the risk for cardiovascular events was highest in the following 2 weeks and stayed elevated more than 1 year after, according to study results ...
Considering all of the data and their limitations, questions still remain regarding the optimal treatment of COPD exacerbations ... only head-to-head trial to date. It is reasonable to recommend ...